Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 41.05
  • 0.15  -0.36%
    Today's Change
  • 41.20
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 10/17/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding51 million
Market Cap$2 billion
Return on Equity ttm56.05%
Last DividendSUPN:US does not pay a dividend
EPS: Year Actual ttm1.135
EPS: Year Est. 12/17 ttm1.040
EPS: Quarterly Actual 6/17 0.32
EPS: Quarterly Est. 9/17 0.27
Price/Earnings ttm36.18
Relative Price/Earnings1.658
Earnings Growth Rate534.48
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$215 million
Net Income$91 million
Total Assets$310 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!